(Q38112269)

English

Oral branched-chain amino acids have a beneficial effect on manifestations of hepatic encephalopathy in a systematic review with meta-analyses of randomized controlled trials.

scientific article published on 05 June 2013

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23739310%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

0 references

Oral branched-chain amino acids have a beneficial effect on manifestations of hepatic encephalopathy in a systematic review with meta-analyses of randomized controlled trials (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23739310%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

0 references

systematic review

1 reference

based on heuristic

inferred from title

hepatic encephalopathy

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23739310%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Giulio Marchesini

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23739310%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Hendrik Vilstrup

9

object named as

Hendrik Vilstrup

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23739310%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

author name string

Gitte Dam

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23739310%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Mette Borre

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23739310%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Iñigo Les

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23739310%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Juan Cordoba

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23739310%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Niels K Aagaard

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23739310%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Niels Risum

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23739310%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

language of work or name

0 references

publication date

5 June 2013

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23739310%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Journal of Nutrition

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23739310%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

143

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23739310%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23739310%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1263-1268

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23739310%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Hepatic Encephalopathy.

1 reference

https://api.crossref.org/works/10.3945%2FJN.113.174375

21 January 2018

Minimal hepatic encephalopathy matters in daily life

1 reference

https://api.crossref.org/works/10.3945%2FJN.113.174375

21 January 2018

Prognosis and 1-year mortality of intensive care unit patients with severe hepatic encephalopathy.

1 reference

https://api.crossref.org/works/10.3945%2FJN.113.174375

21 January 2018

Clinical course of alcoholic liver cirrhosis: a Danish population-based cohort study

1 reference

https://api.crossref.org/works/10.3945%2FJN.113.174375

21 January 2018

Management of hepatic encephalopathy in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.3945%2FJN.113.174375

21 January 2018

Acute-on-chronic liver failure: the brain

1 reference

https://api.crossref.org/works/10.3945%2FJN.113.174375

21 January 2018

Branched-chain-enriched amino acid solutions in patients with liver failure: an early example of nutritional pharmacology

1 reference

https://api.crossref.org/works/10.3945%2FJN.113.174375

21 January 2018

Three targets of branched-chain amino acid supplementation in the treatment of liver disease

1 reference

https://api.crossref.org/works/10.3945%2FJN.113.174375

21 January 2018

The glutamate/GABA-glutamine cycle: aspects of transport, neurotransmitter homeostasis and ammonia transfer.

1 reference

https://api.crossref.org/works/10.3945%2FJN.113.174375

21 January 2018

Role of branched chain amino acids in cerebral ammonia homeostasis related to hepatic encephalopathy.

1 reference

https://api.crossref.org/works/10.3945%2FJN.113.174375

21 January 2018

Diet and cognition in chronic liver disease

1 reference

https://api.crossref.org/works/10.3945%2FJN.113.174375

21 January 2018

Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: a double-blind, randomized trial.

1 reference

https://api.crossref.org/works/10.3945%2FJN.113.174375

21 January 2018

Lactulose, rifaximin or branched chain amino acids for hepatic encephalopathy: what is the evidence?

1 reference

https://api.crossref.org/works/10.3945%2FJN.113.174375

21 January 2018

Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials

1 reference

https://api.crossref.org/works/10.3945%2FJN.113.174375

21 January 2018

Meta-analysis of individual patient data from randomized trials: a review of methods used in practice.

1 reference

https://api.crossref.org/works/10.3945%2FJN.113.174375

21 January 2018

Sequential methods for random-effects meta-analysis

1 reference

https://api.crossref.org/works/10.3945%2FJN.113.174375

21 January 2018

Comparison of dietary protein with an oral, branched chain-enriched amino acid supplement in chronic portal-systemic encephalopathy: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.3945%2FJN.113.174375

21 January 2018

Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998.

1 reference

https://api.crossref.org/works/10.3945%2FJN.113.174375

21 January 2018

Hepatic encephalopathy and health-related quality of life

1 reference

https://api.crossref.org/works/10.3945%2FJN.113.174375

21 January 2018

Rifaximin treatment in hepatic encephalopathy

1 reference

https://api.crossref.org/works/10.3945%2FJN.113.174375

21 January 2018

EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis

1 reference

https://api.crossref.org/works/10.3945%2FJN.113.174375

21 January 2018

Randomised clinical trial: rifaximin improves health-related quality of life in cirrhotic patients with hepatic encephalopathy - a double-blind placebo-controlled study

1 reference

https://api.crossref.org/works/10.3945%2FJN.113.174375

21 January 2018

ESPEN Guidelines on Enteral Nutrition: Liver disease.

1 reference

https://api.crossref.org/works/10.3945%2FJN.113.174375

21 January 2018

Branched chain amino acids enhance the maturation and function of myeloid dendritic cells ex vivo in patients with advanced cirrhosis.

1 reference

https://api.crossref.org/works/10.3945%2FJN.113.174375

21 January 2018

Restoration of innate host defense responses by oral supplementation of branched-chain amino acids in decompensated cirrhotic patients

1 reference

https://api.crossref.org/works/10.3945%2FJN.113.174375

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38112269&oldid=2131322718"